Clinical Trials in Arizona

Showing 7841-7860 of 16,770 trials

Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors

NCT03634982

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetic (PK), and pharmacodynamic (PD) profiles of escalating doses of RMC-4630 monotherapy in adult participants with relapsed/refractory solid tumors and to identify the recommended Phase 2 dose (RP2D).

Solid Tumors

Revolution Medicines, Inc.133 participantsStarted Sep 2018

Scottsdale, Arizona, United States • Duarte, California, United States • Orange, California, United States +9 more locations

COMPLETEDPhase 135 miles

Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin

NCT02542969

The purpose of this study is to determine whether MGL-3196 alters the pharmacokinetics of rosuvastatin and/or simvastatin in healthy male subjects and female subjects not of child-bearing potential.

Healthy

Madrigal Pharmaceuticals, Inc.25 participantsStarted Sep 2015

Tempe, Arizona, United States

TERMINATEDPhase 238 miles

Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Participants With Presumed Nonalcoholic Steatohepatitis (NASH)

NCT03823703

This phase 2, double blind, placebo-controlled, randomized study is to assess the safety and efficacy of miricorilant (CORT118335) in patients with presumed Nonalcoholic Steatohepatitis (NASH).

Nonalcoholic Steatohepatitis (NASH)

Corcept Therapeutics12 participantsStarted Nov 2020

Chandler, Arizona, United States • Glendale, Arizona, United States • Tucson, Arizona, United States +12 more locations

Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors

Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin

Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Participants With Presumed Nonalcoholic Steatohepatitis (NASH)

Find Trials by Condition in Arizona

A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia

Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy

Evaluation of the Use of Medical Scribes in VAMC Emergency Departments and Specialty Care Clinics

A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease

Study to Evaluate the Safety and Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED)

Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Glabellar Lines

Safety and Efficacy Study of DUR-928 Topical Solution in Subjects With Plaque Psoriasis

Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis

The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis

Mentors Offering Maternal Support (M-O-M-S™): A Prenatal Program for Decreasing Maternal Anxiety and Depression

Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines

To Evaluate the Safety, and Pharmacokinetics of Parscaclisib in Participants With Normal Hepatic Function and Hepatic Impairment.

A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms

A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601

Subject Satisfaction With AbobutulinumtoxinA Treatment

Lovastatin for the Treatment of Mildly Active Rheumatoid Arthritis

A Prospective Study of Early Mechanical Stabilization and Bleeding in Disruption of the Pelvic Ring